Market Cap 423.84M
Revenue (ttm) 742.90M
Net Income (ttm) 52.60M
EPS (ttm) N/A
PE Ratio 5.38
Forward PE N/A
Profit Margin 7.08%
Debt to Equity Ratio 1.09
Volume 641,400
Avg Vol 979,766
Day's Range N/A - N/A
Shares Out 52.52M
Stochastic %K 9%
Beta 2.41
Analysts Strong Sell
Price Target $12.00

Company Profile

Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments. The company offers ACAM2000, a smallpox and mpox vaccine; Anthrax Immune Globulin Intravenous (ANTHRASIL), a polyclonal antibody therapeutic for the treatment of inhalational anthrax; Botul...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 240-631-3200
Fax: 240-631-3203
Address:
300 Professional Drive, Suite 400, Gaithersburg, United States
ImmxBeliever
ImmxBeliever Mar. 15 at 6:19 PM
$EBS yes He is a moron We finally agree “Gaap accounting”🤡
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 5:12 PM
$EBS The truth about what? Who cares about profits, when the money is in "FLOWS".
1 · Reply
TeriRasch251
TeriRasch251 Mar. 15 at 5:11 PM
Looking at $EBS and observing how it trades.
0 · Reply
WinstonSmith33
WinstonSmith33 Mar. 15 at 5:05 PM
$EBS Comrade knows the truth, but he uses too much AI and forgets about it every day
0 · Reply
WinstonSmith33
WinstonSmith33 Mar. 15 at 4:38 PM
$EBS It's called risk management. At low prices they buy little, at high prices they buy more. The best example April 2025: only 200k shares at 5.01$. It was the smallest number of shares bought in all 9 months. Someone was probably buying shares then, so they didn't compete. The method of how the "Poor" become "Rich". Clear as day. Now again the price is too low to use buybacks, sorry.
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 4:30 PM
$EBS This is good for us, on so many levels. Elon and his cronies kiboshed PAHPA's congressional passage in that 1,500 CR in December 2024. Elon is gone, but his cronies remain. It appears that the US Administration may now be forced to get in correction mode, and Deep State may loosen the purses again, as their restrain these neophytes, that may have plunged the US into an unconventional war. https://x.com/allenanalysis/status/2032202555388723618
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 1:09 PM
$EBS 2 years of revenue projections are now extant, through HC Wainwrong. I have used the projections nested in the reply, and I come up with a path dependent $17 by Q1 '27. As you see, Rag is more sanguine for 2027 than previously thought.
0 · Reply
Daniel3303
Daniel3303 Mar. 15 at 3:09 AM
$EBS They increased buyback volume every quarter
1 · Reply
alwayzwong
alwayzwong Mar. 14 at 8:32 PM
$EBS market sniffing out a high probability that Republicans will lose the midterms
0 · Reply
Tradewind74
Tradewind74 Mar. 14 at 8:21 PM
$EBS https://www.nyc.gov/site/doh/health/health-topics/mpox.page
0 · Reply
Latest News on EBS
Emergent BioSolutions: Solid Q3, Expecting Better Days To Come

Nov 6, 2025, 11:00 PM EST - 4 months ago

Emergent BioSolutions: Solid Q3, Expecting Better Days To Come


Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally

Aug 12, 2025, 12:46 PM EDT - 7 months ago

Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally


Emergent BioSolutions Announces Addition to Russell 3000® Index

Jun 20, 2025, 8:13 AM EDT - 9 months ago

Emergent BioSolutions Announces Addition to Russell 3000® Index


Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript

May 7, 2025, 10:01 PM EDT - 11 months ago

Emergent BioSolutions Inc. (EBS) Q1 2025 Earnings Call Transcript


Emergent BioSolutions Announces Stock Repurchase Program

Mar 31, 2025, 8:00 AM EDT - 1 year ago

Emergent BioSolutions Announces Stock Repurchase Program


ImmxBeliever
ImmxBeliever Mar. 15 at 6:19 PM
$EBS yes He is a moron We finally agree “Gaap accounting”🤡
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 5:12 PM
$EBS The truth about what? Who cares about profits, when the money is in "FLOWS".
1 · Reply
TeriRasch251
TeriRasch251 Mar. 15 at 5:11 PM
Looking at $EBS and observing how it trades.
0 · Reply
WinstonSmith33
WinstonSmith33 Mar. 15 at 5:05 PM
$EBS Comrade knows the truth, but he uses too much AI and forgets about it every day
0 · Reply
WinstonSmith33
WinstonSmith33 Mar. 15 at 4:38 PM
$EBS It's called risk management. At low prices they buy little, at high prices they buy more. The best example April 2025: only 200k shares at 5.01$. It was the smallest number of shares bought in all 9 months. Someone was probably buying shares then, so they didn't compete. The method of how the "Poor" become "Rich". Clear as day. Now again the price is too low to use buybacks, sorry.
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 4:30 PM
$EBS This is good for us, on so many levels. Elon and his cronies kiboshed PAHPA's congressional passage in that 1,500 CR in December 2024. Elon is gone, but his cronies remain. It appears that the US Administration may now be forced to get in correction mode, and Deep State may loosen the purses again, as their restrain these neophytes, that may have plunged the US into an unconventional war. https://x.com/allenanalysis/status/2032202555388723618
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 15 at 1:09 PM
$EBS 2 years of revenue projections are now extant, through HC Wainwrong. I have used the projections nested in the reply, and I come up with a path dependent $17 by Q1 '27. As you see, Rag is more sanguine for 2027 than previously thought.
0 · Reply
Daniel3303
Daniel3303 Mar. 15 at 3:09 AM
$EBS They increased buyback volume every quarter
1 · Reply
alwayzwong
alwayzwong Mar. 14 at 8:32 PM
$EBS market sniffing out a high probability that Republicans will lose the midterms
0 · Reply
Tradewind74
Tradewind74 Mar. 14 at 8:21 PM
$EBS https://www.nyc.gov/site/doh/health/health-topics/mpox.page
0 · Reply
ImmxBeliever
ImmxBeliever Mar. 14 at 7:01 PM
$EBS daddy won Immx is where it’s at
0 · Reply
ImmxBeliever
ImmxBeliever Mar. 14 at 7:01 PM
$EBS Facts
0 · Reply
billywilliamz
billywilliamz Mar. 14 at 3:56 PM
$EBS uh oh mom and dad are fighting again…
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 14 at 1:29 PM
$EBS This is history, and if they get 1 quarter of operating/gaap loss out of 4, so be it. What does this have to do with the refinancing sequence optimizaton? Do they have the cash to pay off their $150M in toxic debt? If yes, then this stock is really in a option to paying the toxic debt off in June. Since it isn't a 'stock' (ie a claim on equity) until OHA is gone, then looking at GAAP anything is irrelevant.
1 · Reply
IntelligunInvestings
IntelligunInvestings Mar. 14 at 5:02 AM
$EBS full disclosure i sold today 95% pretty much feels fair to tell everyone with war and this uncertain crossover period i had too much in this to risk it i will surely buy again but want wait and not risk going negative i love a lot of you in this page and thank you for all the good info and morale
0 · Reply
WinstonSmith33
WinstonSmith33 Mar. 14 at 4:53 AM
$EBS non-delusional Q4 reality: Operating net loss: -15.7M$ (not profitable company anymore, other words: No CaSh FlOw HeRe) (non operating) Interest expense: -14.7M$ Impairment: -12.2M$ (you can expect more of them in the future) Net loss: -54.6M$ Book value in Q4: -59.9M$ (the company loses value) And guess what. H1 with 300M$ expected revenues (150M$ in Q1 and Q2) will be pretty similar.
1 · Reply
ComradeKomisar
ComradeKomisar Mar. 13 at 8:15 PM
$EBS Absent any news of incremental orders, this play has turned into a spreadsheet at this point. The new entrant to the board of directors is probably playing with it as we speak. I can do that too, and it is telling me: 1) EBS will hint at having started refinancing efforts in May. 2)pay off OHA in totality in June 3) start shopping around the senior notes in September This has to be a highly coordinated play, because it would have to involve BARDA/SNS paying their accounts receivable on time, early in June. Meanwhile, through a quirk of that international order last year, the buyback window is open through June as well. I suspect they will by a minimum of $10M shares in the interim. $40M in Q1 '27 This should be $12-$15 by September.
1 · Reply
ImmxBeliever
ImmxBeliever Mar. 13 at 5:40 PM
0 · Reply
alwayzwong
alwayzwong Mar. 13 at 4:19 PM
$EBS late cycle monkey business
1 · Reply
ImmxBeliever
ImmxBeliever Mar. 12 at 9:44 PM
$EBS hopium
0 · Reply
ComradeKomisar
ComradeKomisar Mar. 12 at 8:29 PM
$EBS I was hoping we'd get a earnout payment from Bavarian for $30M based on the sales of the 2 vaccines they acquired from us. Looks like those products have yet to prove themselves commercially.
0 · Reply
GrantDiaz
GrantDiaz Mar. 12 at 7:13 PM
$EBS Down less than half of our related indexes. That shows you we're pretty much already priced near the floor. Any significantly positive contracts, news, biological attacks, etc, could send this up 10% to 20% or more.
1 · Reply